Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Capital Expenditures

1.6 / 5 stars · 38/120 Roast Me

ENANTA PHARMACEUTICALS, INC Capital Expenditures

ENANTA PHARMACEUTICALS, INC (ENTA) reported Capital Expenditures of $165.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-12

  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $7.00K, a 95.48% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $15.00K, a 99.41% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $143.00K, a 98.36% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.46M, a 83.71% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for fiscal 2025 was $12.90M, a 28.15% decline from fiscal 2024.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for fiscal 2024 was $17.95M, a 98.15% increase from fiscal 2023.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for fiscal 2023 was $9.06M, a 326.26% increase from fiscal 2022.
  • ENANTA PHARMACEUTICALS, INC payments to acquire property, plant, and equipment for fiscal 2022 was $2.13M, a 183.33% increase from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$22.00K
derived: sum of 2 quarters · filed 2026-08-12
$165.00K
10-Q · filed 2026-08-12
$1.62M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
$158.00K
10-Q · filed 2026-05-13
$1.62M
derived: sum of 3 quarters · filed 2026-05-13
$1.77M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$143.00K
10-Q · filed 2026-02-11
$1.60M
derived: sum of 2 quarters · filed 2026-02-11
$1.76M
derived: sum of 3 quarters · filed 2026-08-12
$4.29M
derived: sum of 4 quarters · filed 2026-08-12
2025-09-30$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$1.61M
derived: sum of 2 quarters · filed 2026-08-12
$4.15M
derived: sum of 3 quarters · filed 2026-08-12
$12.90M
10-K · filed 2025-11-19
2025-06-30$155.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$2.69M
derived: sum of 2 quarters · filed 2026-08-12
$11.44M
10-Q · filed 2026-08-12
$20.39M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
$11.28M
10-Q · filed 2026-05-13
$20.23M
derived: sum of 3 quarters · filed 2026-05-13
$26.78M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$8.74M
10-Q · filed 2026-02-11
$17.70M
derived: sum of 2 quarters · filed 2026-02-11
$24.24M
derived: sum of 3 quarters · filed 2026-02-11
$25.91M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30$8.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$15.49M
derived: sum of 2 quarters · filed 2025-11-19
$17.16M
derived: sum of 3 quarters · filed 2025-11-19
$17.95M
10-K · filed 2025-11-19
2024-06-30$6.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13
$8.21M
derived: sum of 2 quarters · filed 2025-08-13
$9.00M
10-Q · filed 2025-08-13
$10.37M
derived: sum of 4 quarters · filed 2025-11-19
2024-03-31$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14
$2.46M
10-Q · filed 2025-05-14
$3.82M
derived: sum of 3 quarters · filed 2025-11-19
$5.97M
derived: sum of 4 quarters · filed 2025-11-19
2023-12-31$787.00K
10-Q · filed 2025-02-12
$2.15M
derived: sum of 2 quarters · filed 2025-11-19
$4.31M
derived: sum of 3 quarters · filed 2025-11-19
$6.69M
derived: sum of 4 quarters · filed 2025-11-19
2023-09-30$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$3.52M
derived: sum of 2 quarters · filed 2025-11-19
$5.90M
derived: sum of 3 quarters · filed 2025-11-19
$9.06M
10-K · filed 2025-11-19
2023-06-30$2.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07
$4.53M
derived: sum of 2 quarters · filed 2024-08-07
$7.69M
10-Q · filed 2024-08-07
$9.13M
derived: sum of 4 quarters · filed 2024-11-27
2023-03-31$2.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08
$5.54M
10-Q · filed 2024-05-08
$6.98M
derived: sum of 3 quarters · filed 2024-11-27
$7.23M
derived: sum of 4 quarters · filed 2024-11-27
2022-12-31$3.16M
10-Q · filed 2024-02-08
$4.59M
derived: sum of 2 quarters · filed 2024-11-27
$4.84M
derived: sum of 3 quarters · filed 2024-11-27
$4.92M
derived: sum of 4 quarters · filed 2024-11-27
2022-09-30$1.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27
$1.69M
derived: sum of 2 quarters · filed 2024-11-27
$1.76M
derived: sum of 3 quarters · filed 2024-11-27
$2.13M
10-K · filed 2024-11-27
2022-06-30$251.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08
$325.00K
derived: sum of 2 quarters · filed 2023-08-08
$688.00K
10-Q · filed 2023-08-08
$721.00K
derived: sum of 4 quarters · filed 2023-11-22
2022-03-31$74.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09
$437.00K
10-Q · filed 2023-05-09
$470.00K
derived: sum of 3 quarters · filed 2023-11-22
$869.00K
derived: sum of 4 quarters · filed 2023-11-22
2021-12-31$363.00K
10-Q · filed 2023-02-08
$396.00K
derived: sum of 2 quarters · filed 2023-11-22
$795.00K
derived: sum of 3 quarters · filed 2023-11-22
$925.00K
derived: sum of 4 quarters · filed 2023-11-22
2021-09-30$33.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22
$432.00K
derived: sum of 2 quarters · filed 2023-11-22
$562.00K
derived: sum of 3 quarters · filed 2023-11-22
$750.00K
10-K · filed 2023-11-22
2021-06-30$399.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08
$529.00K
derived: sum of 2 quarters · filed 2022-08-08
$717.00K
10-Q · filed 2022-08-08
$1.05M
derived: sum of 4 quarters · filed 2022-11-23
2021-03-31$130.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09
$318.00K
10-Q · filed 2022-05-09
$648.00K
derived: sum of 3 quarters · filed 2022-11-23
$921.00K
derived: sum of 4 quarters · filed 2022-11-23
2020-12-31$188.00K
10-Q · filed 2022-02-10
$518.00K
derived: sum of 2 quarters · filed 2022-11-23
$791.00K
derived: sum of 3 quarters · filed 2022-11-23
$1.15M
derived: sum of 4 quarters · filed 2022-11-23
2020-09-30$330.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23
$603.00K
derived: sum of 2 quarters · filed 2022-11-23
$957.00K
derived: sum of 3 quarters · filed 2022-11-23
$1.45M
10-K · filed 2022-11-23
2020-06-30$273.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09
$627.00K
derived: sum of 2 quarters · filed 2021-08-09
$1.11M
10-Q · filed 2021-08-09
$1.41M
derived: sum of 4 quarters · filed 2021-11-24
2020-03-31$354.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10
$842.00K
10-Q · filed 2021-05-10
$1.14M
derived: sum of 3 quarters · filed 2021-11-24
$3.37M
derived: sum of 4 quarters · filed 2021-11-24
2019-12-31$488.00K
10-Q · filed 2021-02-09
$784.00K
derived: sum of 2 quarters · filed 2021-11-24
$3.01M
derived: sum of 3 quarters · filed 2021-11-24
$5.52M
derived: sum of 4 quarters · filed 2021-11-24
2019-09-30$296.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
$2.53M
derived: sum of 2 quarters · filed 2021-11-24
$5.03M
derived: sum of 3 quarters · filed 2021-11-24
$5.42M
10-K · filed 2021-11-24
2019-06-30$2.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10
$4.74M
derived: sum of 2 quarters · filed 2020-08-10
$5.12M
10-Q · filed 2020-08-10
$5.74M
derived: sum of 4 quarters · filed 2020-11-25
2019-03-31$2.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11
$2.89M
10-Q · filed 2020-05-11
$3.51M
derived: sum of 3 quarters · filed 2020-11-25
$4.62M
derived: sum of 4 quarters · filed 2020-11-25
2018-12-31$384.00K
10-Q · filed 2020-02-10
$1.01M
derived: sum of 2 quarters · filed 2020-11-25
$2.11M
derived: sum of 3 quarters · filed 2020-11-25
$2.86M
derived: sum of 4 quarters · filed 2020-11-25
2018-09-30$623.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25
$1.73M
derived: sum of 2 quarters · filed 2020-11-25
$2.48M
derived: sum of 3 quarters · filed 2020-11-25
$2.98M
10-K · filed 2020-11-25
2018-06-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09
$1.85M
derived: sum of 2 quarters · filed 2019-08-09
$2.36M
10-Q · filed 2019-08-09
$2.59M
derived: sum of 4 quarters · filed 2019-11-27
2018-03-31$752.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10
$1.26M
10-Q · filed 2019-05-10
$1.49M
derived: sum of 3 quarters · filed 2019-11-27
$2.23M
derived: sum of 4 quarters · filed 2019-11-27
2017-12-31$504.00K
10-Q · filed 2019-02-08
$738.00K
derived: sum of 2 quarters · filed 2019-11-27
$1.48M
derived: sum of 3 quarters · filed 2019-11-27
$2.06M
derived: sum of 4 quarters · filed 2019-11-27
2017-09-30$234.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27
$975.00K
derived: sum of 2 quarters · filed 2019-11-27
$1.55M
derived: sum of 3 quarters · filed 2019-11-27
$2.51M
10-K · filed 2019-11-27
2017-06-30$741.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09
$1.32M
derived: sum of 2 quarters · filed 2018-08-09
$2.27M
10-Q · filed 2018-08-09
$2.69M
derived: sum of 4 quarters · filed 2018-11-29
2017-03-31$578.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10
$1.53M
10-Q · filed 2018-05-10
$1.95M
derived: sum of 3 quarters · filed 2018-11-29
$2.56M
derived: sum of 4 quarters · filed 2018-11-29
2016-12-31$953.00K
10-Q · filed 2018-02-09
$1.37M
derived: sum of 2 quarters · filed 2018-11-29
$1.98M
derived: sum of 3 quarters · filed 2018-11-29
$3.49M
derived: sum of 4 quarters · filed 2018-11-29
2016-09-30$415.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
$1.03M
derived: sum of 2 quarters · filed 2018-11-29
$2.54M
derived: sum of 3 quarters · filed 2018-11-29
$4.74M
10-K · filed 2018-11-29
2016-06-30$613.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
$2.13M
derived: sum of 2 quarters · filed 2017-08-09
$4.32M
10-Q · filed 2017-08-09
$5.90M
derived: sum of 4 quarters · filed 2017-12-11
2016-03-31$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10
$3.71M
10-Q · filed 2017-05-10
$5.29M
derived: sum of 3 quarters · filed 2017-12-11
$5.69M
derived: sum of 4 quarters · filed 2017-12-11
2015-12-31$2.20M
10-Q · filed 2017-02-09
$3.78M
derived: sum of 2 quarters · filed 2017-12-11
$4.18M
derived: sum of 3 quarters · filed 2017-12-11
$4.28M
derived: sum of 4 quarters · filed 2017-12-11
2015-09-30$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11
$1.98M
derived: sum of 2 quarters · filed 2017-12-11
$2.08M
derived: sum of 3 quarters · filed 2017-12-11
$2.34M
10-K · filed 2017-12-11
2015-06-30$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$500.00K
derived: sum of 2 quarters · filed 2016-08-09
$756.00K
10-Q · filed 2016-08-09
$1.24M
derived: sum of 4 quarters · filed 2016-12-09
2015-03-31$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10
$356.00K
10-Q · filed 2016-05-10
$841.00K
derived: sum of 3 quarters · filed 2016-12-09
$1.22M
derived: sum of 4 quarters · filed 2016-12-09
2014-12-31$256.00K
10-Q · filed 2016-02-09
$741.00K
derived: sum of 2 quarters · filed 2016-12-09
$1.12M
derived: sum of 3 quarters · filed 2016-12-09
$1.26M
derived: sum of 4 quarters · filed 2016-12-09
2014-09-30$485.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09
$863.00K
derived: sum of 2 quarters · filed 2016-12-09
$1.00M
derived: sum of 3 quarters · filed 2016-12-09
$1.03M
10-K · filed 2016-12-09
2014-06-30$378.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$519.00K
derived: sum of 2 quarters · filed 2015-08-10
$543.00K
10-Q · filed 2015-08-10
$745.00K
derived: sum of 4 quarters · filed 2015-12-11
2014-03-31$141.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08
$165.00K
10-Q · filed 2015-05-08
$367.00K
derived: sum of 3 quarters · filed 2015-12-11
$419.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-12-31$24.00K
10-Q · filed 2015-02-06
$226.00K
derived: sum of 2 quarters · filed 2015-12-11
$278.00K
derived: sum of 3 quarters · filed 2015-12-11
$619.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-09-30$202.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11
$254.00K
derived: sum of 2 quarters · filed 2015-12-11
$595.00K
derived: sum of 3 quarters · filed 2015-12-11
$606.00K
10-K · filed 2015-12-11
2013-06-30$52.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12
$393.00K
derived: sum of 2 quarters · filed 2014-08-12
$404.00K
10-Q · filed 2014-08-12
$515.00K
derived: sum of 4 quarters · filed 2014-12-11
2013-03-31$341.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12
$352.00K
10-Q · filed 2014-05-12
$463.00K
derived: sum of 3 quarters · filed 2014-12-11
$510.00K
derived: sum of 4 quarters · filed 2014-12-11
2012-12-31$11.00K
10-Q · filed 2014-02-13
$122.00K
derived: sum of 2 quarters · filed 2014-12-11
$169.00K
derived: sum of 3 quarters · filed 2014-12-11
2012-09-30$111.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11
$158.00K
derived: sum of 2 quarters · filed 2014-12-11
$252.00K
10-K · filed 2014-12-11
2012-06-30$47.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12
$141.00K
10-Q · filed 2013-08-12
2012-03-31$94.00K
10-Q · filed 2013-05-15
2011-09-30$445.00K
10-K · filed 2013-12-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63